Compare Ascendis Pharma A/S (ASND) vs Sea Limited (SE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Sea Limited — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Sea Limited trades at $129.94 (market cap $80.55B). The key difference: Sea Limited is far larger — about 4.8× Ascendis Pharma A/S's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Sea Limited nearer its low. Which is the better fit depends on your goals.
| ASND | SE | |
|---|---|---|
Market Cap | $16.67B | $80.55B |
Sector | Health | Media |
52-Week High | $277.18 | $196.50 |
52-Week Low | $189.74 | $78.16 |
Enterprise Value | $17.04B | $75.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Sea Limited
Sea Limited offers information technology services. The Company provides online personal computer and mobile digital content, e-commerce, and payment platforms. Sea serves customers worldwide.
Read more on SE →
